| Application no. and date | 14198829.5 (espacenet) (Federated) (European Patent Register), 20071030 | | Patent/reg. no. and date | DK/EP 2898887, 20180926 | | Publication date | 20150729 | | Priority no. and date | US 855583 P, 20061030 | | EP pub. no. and date |
EP 2898887 20150729 | | Effective date | | | Applicant/owner | GERON CORPORATION, 149 Commonwealth Drive
Menlo Park, CA 94025, US | | Applicant ref. no. | P23753DKEP | | Inventor | TRESSLER, Robert J., 4675 Clares Street
Capitola, CA 95010, US,
Go, Ning, 524 Timberwood Avenue
Thousands Oaks, CA 91360, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/70 (2006.01) | | Title | Kombination af telomeraseinhibitor og gemcitabin til behandling af cancer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
